Best in Biotech 3 Oct 2024 Six biotechs driving progress in Duchenne muscular dystrophy In this article, we take a look at six clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space. October 3, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2024 The race for a bird flu vaccine: milestones and breakthroughs The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak. September 30, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 27 Sep 2024 Aptadir Therapeutics launches to develop new class of RNA inhibitors against cancer and genetic disorders Italian startup Aptadir Therapeutics has launched with $1.6 million to bring a new class of drugs to the clinic and a technology to be reckoned with. September 27, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Sep 2024 Europe’s rising biotech stars: 10 startups to watch in 2024 The European biotech industry is bustling with activity this year. Here’s a list of 10 European biotech companies likely to make a big splash. September 26, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 20 Sep 2024 Mitigating hot flashes: new therapies for menopause on the rise New therapies could address menopause symptoms, a field in which many treatment gaps still exist. September 20, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 19 Sep 2024 Mitochondrial disease treatments: is a breakthrough on the horizon? Mitochondrial dysfunction is linked to many diseases. Discover how biotechs are developing mitochondrial disease treatments to address these diseases. September 19, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 12 Sep 2024New treatments being developed for schizophrenia Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials. September 12, 2024 Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2024 Long non-coding RNAs: what’s behind the growing “dark genome” buzz? Recent deals have zoned in on drugs that target long non-coding RNAs and major moves are currently being made on the R&D front. September 10, 2024 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Sep 2024 Six biotech companies that could revolutionize obesity treatments In this article, we take a look at six biotechs focused on bringing drugs to treat obesity to the market. September 5, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Sep 2024 2024: a year of breakthroughs for endometrial cancer? New treatments have been approved by regulators for endometrial cancer, which are regarded as major therapeutic breakthroughs. September 4, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 28 Aug 2024 GLP-1 shortage: Can biotech companies keep up with rising demand? How is the biotech industry responding to the GLP-1 drug shortage? We asked experts in the field to answer this question. August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 20 Aug 2024 Fighting mpox: promising vaccines to watch As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical trials are underway to combat the outbreak. August 20, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email